Phase 3 Study of Ripasudil (K-321) Eye Drops in Patients with Fuchs Endothelial Corneal Dystrophy
This 72-week study is testing a new eye injection (BI 764524) to see if it can safely slow or improve diabetic eye disease in people with moderate to severe non-proliferative diabetic retinopathy.
This UK study is testing whether a vitamin (nicotinamide) can help protect vision in people with glaucoma when added to standard eye pressure treatments.
This study compares two surgeries for retinal detachment: one that fixes the retina and removes the lens at the same time, and one that delays lens removal until needed.
This study uses advanced eye scans to track healing after glaucoma surgery and spot early signs of failure, which can lead to vision loss.
This study is creating a UK-wide registry to track outcomes of a laser treatment for glaucoma (MPTLT), aiming to provide strong evidence of how well it works.
This study is testing whether a simpler injection schedule (“Light Touch”) for a new eye drug (faricimab) works just as well as the standard approach in people with wet AMD.
This study is testing whether a newer, quicker eye scan (OCTA) can reliably diagnose wet age-related macular degeneration (nAMD), instead of using older dye-based tests.
This study compares two treatments for severe diabetic macular oedema: ongoing eye injections alone, or injections followed by a gentle laser once swelling improves.
This study will look at how well a medication works to improve vision and reduce eye changes in people with polypoidal choroidal vasculopathy. All participants will receive regular eye injections and be monitored over time to assess improvements in vision, treatment durability, and safety using scans and eye exams.
This study is testing new treatments that may help slow the progression of geographic atrophy, an advanced form of age-related macular degeneration. Participants will receive either investigational medications or a placebo by injection under the skin.
This study is testing a new gene therapy that may help treat wet age-related macular degeneration by reducing the need for frequent eye injections. Participants will receive the treatment through an eye injection and be monitored for safety and effectiveness.
This study is testing a new one‑off eye treatment to see if it is safe and helpful for people with wet age‑related macular degeneration. It will look at different doses to find the safest and most effective amount.
This study is testing an implant called to see if it is safe and easy for doctors to use in people with open‑angle glaucoma. It will also check how well the device helps lower eye pressure to protect vision.
This study is testing a new oral treatment to see how safe and effective it is for people with diabetic‑related eye swelling. Around 300 participants will be randomly assigned to different dose levels or a placebo to compare how well the treatment improves vision and reduces swelling.
